CVR number 39357585
Industry 72.1900 Other research and experimental development on natural sciences and engineering

Cathtracker ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...
Bankruptcy Risk 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 12.4% 31.8% 17.4%  
Credit score (0-100)  0 0 20 1 9  
Credit rating  N/A N/A BB C B  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 -0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -21.5 -22.8 -8.8  
EBITDA  0.0 0.0 -21.5 -83.7 -8.8  
EBIT  0.0 0.0 -21.5 -83.7 -8.8  
Pre-tax profit (PTP)  0.0 0.0 -22.2 -84.8 -10.7  
Net earnings  0.0 0.0 -22.2 -84.8 -10.7  
Pre-tax profit without non-rec. items  0.0 0.0 -22.2 -84.8 -10.7  
 
See the entire income statement

Balance sheet (kDKK) 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  0.0 0.0 27.8 -57.0 -67.7  
Interest-bearing liabilities  0.0 0.0 13.2 13.8 14.7  
Balance sheet total (assets)  0.0 0.0 60.9 0.0 0.0  
Net Debt  0.0 0.0 13.2 13.8 14.7  
 
See the entire balance sheet

Volume 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -21.5 -22.8 -8.8  
Gross profit growth  0.0% 0.0% 0.0% -6.4% 61.4%  
Employees  0 0 0 0 0  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 61 0 0  
Balance sheet change%  0.0% 0.0% 0.0% -100.0% 0.0%  
Added value  0.0 0.0 -21.5 -83.7 -8.8  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 61 -61 0  
Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 -3.0  

Profitability 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 100.0% 366.8% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -35.2% -142.1% -7.1%  
ROI %  0.0% 0.0% -52.3% -305.5% -30.9%  
ROE %  0.0% 0.0% -79.8% -609.6% 0.0%  

Solidity 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Equity ratio %  0.0% 0.0% 45.7% -100.0% -100.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -61.6% -16.4% -167.0%  
Gearing %  0.0% 0.0% 47.6% -24.2% -21.7%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 11.0% 7.8% 13.4%  

Liquidity 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Quick Ratio  0.0 0.0 0.0 0.0 0.0  
Current Ratio  0.0 0.0 0.0 0.0 0.0  
Cash and cash equivalent  0.0 0.0 0.0 0.0 0.0  

Capital use efficiency 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -19.9 -43.2 -53.4  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2016
N/A
2017
N/A
2018
2019/6
2019
2020/6
2020
2021/6
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 0 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 0 0  
EBIT / employee  0 0 0 0 0  
Net earnings / employee  0 0 0 0 0